Learn more about the novel combination of state-of-the-art ultrasound and opto-acoustic (sometimes referred to as photoacoustic) technology
Get a live demo at your facility as the Imagio® OA/US Roadshow crosses the country. Click here for latest updates and request a stop.
Scans Across America
Pioneered by Seno Medical, Opto-Acoustic/Ultrasound (OA/US) shines a new light on breast cancer diagnostics, enabling a real-time assessment to differentiate malignant from benign breast tissue.
FDA approval of Imagio® Breast Imaging System offers breast centers a unique opportunity to enhance the patient experience by reducing biopsies of benign masses.
Without dyes, radiation, or invasive procedures, Imagio® provides the clinician an immediate, objective diagnosis leveraging the AI-driven clinical decision support tool, SenoGram®.
See Imagio® and SenoGram® in action with a clinical demonstration of OA/US technology and examples of images that can differentiate malignant and benign breast tissue on screen and in color, with the painless, real-time OA/US scan.
See Imagio® and SenoGram® in action with a clinical demonstration of OA/US technology and examples of images that can differentiate malignant and benign breast tissue on screen and in color, with the painless, real-time OA/US scan.
Talk to a Seno Medical sales rep for more information about the latest technological advancements and how you can bring the novel combination of state-of-the-art ultrasound and groundbreaking opto-acoustic technology to your facility.
See ROI example »